Daniel Segenreich M.D., Ph.D., is a Brazilian Psychiatrist with a private practice based in Rio de Janeiro, Brazil. He is a graduate of the Medicine School of Rio de Janeiro Federal University where he received both his M.D. and Ph.D. from the Psychiatry Institute. Since the late 1990s, Dr. Segenreich has specialized in ADHD and Psychopharmacology, with a special interest in psychoeducation for increasing treatment adherence. He also works as a scientific counsellor for the Brazilian Attention Deficit Society (ABDA), a non-profit organization that helps people with ADHD and their families.
Dr. Segenreich has published significant research studies in the Journal of Attention Disorders, European Child and Adolescent Psychiatry, and Brazilian Journal of Medical and Biological Research. His last study investigated the aggregation of symptoms of ADHD, anxiety, and depression in families of children with ADHD.
Grants and Funding: We proudly support the research and programs of 501(c)(3) non-profit organizations and institutions such as: the Anxiety Disorders program of the Jane & Terry Semel Institute for Neuroscience & Human Behavior at the University of California, Los Angeles; the Pacific Institute of Medical Research; the International Foundation for Research and Education on Depression (iFred); and SchoolsForHope.org, an iFred educational project. Working with these partners enables Anxiety.org to extend its commitment to its mission. All the donations received, as well as 100% of Anxiety.org revenue in 2019, will be contributed to build, develop, and further the understanding, investigation, discovery, and treatment of the full spectrum of anxiety and related disorders.